NCT05122195

Brief Summary

This study will be evaluate the clinical efficacy of using graduated compression hosiery for venospecific symptoms, leg edema, and quality of life (QoL) in pregnant women with varicose veins (VV's).

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jun 2021

Shorter than P25 for all trials

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2021

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

November 5, 2021

Completed
10 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 15, 2021

Completed
1 day until next milestone

First Posted

Study publicly available on registry

November 16, 2021

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2022

Completed
Last Updated

November 24, 2021

Status Verified

November 1, 2021

Enrollment Period

6 months

First QC Date

November 5, 2021

Last Update Submit

November 16, 2021

Conditions

Keywords

VV'sGSVSSVQoL

Outcome Measures

Primary Outcomes (16)

  • Responders to Treatment, Assessed by Duplex Ultrasound

    Responders; Number of Participants with eliminated superficial pathological reflux between the 20th and 28th weeks of gestation

    8 weeks

  • Responders to Treatment, Assessed by Duplex Ultrasound

    Responders; Number of Participants with eliminated superficial pathological reflux between the 28th and 36th weeks of gestation

    16 weeks

  • Number of Participants with reduction of the GSV and SSV diameters, Assessed by Duplex Ultrasound

    Responders; reduction of the GSV and SSV diameters between the 20th and 28th weeks of gestation

    8 weeks

  • Number of Participants with reduction of the GSV and SSV diameters, Assessed by Duplex Ultrasound

    Responders; Number of Participants with reduction of the GSV and SSV diameters between the 28th and 36th weeks of gestation

    16 weeks

  • Responders to Treatment, Assessed by a measuring tape

    Responders; Number of Participants with reduction of the ankle and lower leg circumference between the 20th and 28th weeks of gestation

    8 weeks

  • Responders to Treatment, Assessed by a measuring tape

    Responders; Number of Participants with reduction of the ankle and lower leg circumference between the 28th and 36th weeks of gestation

    16 weeks

  • Number of Participants with pain from absent (score 0) to severe (score 3)

    None (0), Occasional (1), Daily, intefering with, but not preventing daily activities (2), Daily, limiting most daily activities (3)

    8 weeks

  • Number of Participants with pain from absent (score 0) to severe (score 3)

    None (0), Occasional (1), Daily, intefering with, but not preventing daily activities (2), Daily, limiting most daily activities (3)

    16 weeks

  • Number of Participants with heavy legs from absent (score 0) to severe (score 3)

    None (0), Occasional (1), Daily, intefering with, but not preventing daily activities (2), Daily, limiting most daily activities (3)

    8 weeks

  • Number of Participants with heavy legs from absent (score 0) to severe (score 3)

    None (0), Occasional (1), Daily, intefering with, but not preventing daily activities (2), Daily, limiting most daily activities (3)

    16 weeks

  • Number of Participants with tired legs from absent (score 0) to severe (score 3)

    None (0), Occasional (1), Daily, intefering with, but not preventing daily activities (2), Daily, limiting most daily activities (3)

    8 weeks

  • Number of Participants with tired legs from absent (score 0) to severe (score 3)

    None (0), Occasional (1), Daily, intefering with, but not preventing daily activities (2), Daily, limiting most daily activities (3)

    16 weeks

  • Number of Participants with sensation of tension from absent (score 0) to severe (score 3)

    None (0), Occasional (1), Daily, intefering with, but not preventing daily activities (2), Daily, limiting most daily activities (3)

    8 weeks

  • Number of Participants with sensation of tension from absent (score 0) to severe (score 3)

    None (0), Occasional (1), Daily, intefering with, but not preventing daily activities (2), Daily, limiting most daily activities (3)

    16 weeks

  • Number of Participants with tingling from absent (score 0) to severe (score 3)

    None (0), Occasional (1), Daily, intefering with, but not preventing daily activities (2), Daily, limiting most daily activities (3)

    8 weeks

  • Number of Participants with tingling from absent (score 0) to severe (score 3)

    None (0), Occasional (1), Daily, intefering with, but not preventing daily activities (2), Daily, limiting most daily activities (3)

    16 weeks

Study Arms (2)

Group A, compression therapy group

Elastic compression therapy with a thigh length stockings of 23-32 mmHg, at least 8 hours a day.

Other: Compression therapy

Group B, control group

No compression therapy prescribed in the follow-up period.

Interventions

Graduated elastic compression promote venous flow which is impaired by hormonal changes in the venous system during the gestational period and minimize the blocking effect of the gravid uterus.

Group A, compression therapy group

Eligibility Criteria

Age18 Years - 40 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

Pregnant women (between the 12th and 15th weeks of gestation) with primary varicose vein disease and C1-C3 are included in the prospective consecutive case study if they satisfied the selection criteria.

You may qualify if:

  • Pregnant women who are between the 12th and 15th weeks of gestation.
  • Primary symptomatic varicose veins, Clinical Etiological Anatomical Pathophysiological (CEAP) classification, clinical class C1-C3.
  • Ability to comprehend and sign an informed consent document.

You may not qualify if:

  • Deep venous thrombosis, thrombophilia associated with a high risk of deep venous thrombosis or postthrombotic syndrome.
  • Postoperative varicose vein disease recurrence.
  • History of pulmonary embolism.
  • Current compression therapy (within 7 days of enrollment).
  • CEAP clinical class C4-C6.
  • Arterial occlusive disease and lymphatic pathology of lower limbs.
  • Edema of limbs other than of venous origin.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Vladimir Khryshchanovich

Minsk, Minsk Oblast, 220116, Belarus

RECRUITING

Belarusian State Medical University

Minsk, 220116, Belarus

RECRUITING

Related Publications (4)

  • Allegra C, Antignani PL, Will K, Allaert F. Acceptance, compliance and effects of compression stockings on venous functional symptoms and quality of life of Italian pregnant women. Int Angiol. 2014 Aug;33(4):357-64.

  • Gardenghi LA, Dezotti NRA, Dalio MB, Martins WP, Joviliano EE, Piccinato CE. Lower limb venous diameters and haemodynamics during pregnancy and postpartum period in healthy primigravidae. Phlebology. 2017 Dec;32(10):670-678. doi: 10.1177/0268355516671586. Epub 2016 Dec 6.

  • Smyth RM, Aflaifel N, Bamigboye AA. Interventions for varicose veins and leg oedema in pregnancy. Cochrane Database Syst Rev. 2015 Oct 19;2015(10):CD001066. doi: 10.1002/14651858.CD001066.pub3.

  • Thaler E, Huch R, Huch A, Zimmermann R. Compression stockings prophylaxis of emergent varicose veins in pregnancy: a prospective randomised controlled study. Swiss Med Wkly. 2001 Dec 1;131(45-46):659-62. doi: 10.4414/smw.2001.09805.

MeSH Terms

Conditions

Varicose Veins

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular Diseases

Study Officials

  • Vladimir Khryshchanovich

    Educational Institution "Belarusian State Medical University"

    STUDY CHAIR

Central Study Contacts

Vladimir Khryshchanovich

CONTACT

Nicolay Rogovoy, MD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

November 5, 2021

First Posted

November 16, 2021

Study Start

June 1, 2021

Primary Completion

November 15, 2021

Study Completion

May 1, 2022

Last Updated

November 24, 2021

Record last verified: 2021-11

Data Sharing

IPD Sharing
Will share

To evaluate the clinical efficacy of using graduated compression hosiery for venospecific symptoms, leg edema, and quality of life in pregnant women with varicose veins (VV's).

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
Time Frame
05.2022
Access Criteria
To evaluate the clinical efficacy of using graduated compression hosiery for venospecific symptoms, leg edema, and quality of life in pregnant women with varicose veins (VV's).

Locations